|
|
||||||||



*
Department of Cell and Microbiology, Institute of Microbiology and Genetics, Vienna Biocenter, Vienna, Austria;
Department of Experimental Medicine and Biochemical Sciences, University of Rome "Tor Vergata," Rome, Italy;
Institut für Pharmakologie und Toxikologie, Freiburg, Germany; and
§
Protein Phosphorylation Lab, Imperial Cancer Research Fund, London United Kingdom
| Abstract |
|---|
|
|
|---|
. SEK1 is stimulated by a distinct mechanism involving
phosphatidylcholine-phospholipase C and acidic sphingomyelinase.
Dominant-negative SEK1 can block JNK activation by LPS, but not by
Salmonella. These data demonstrate that SEK1 and JNK are
activated independently in Salmonella-infected
macrophages and offer experimental support for the concept that
incoming signals can direct the selective coupling of downstream
pathways to elicit highly specific responses. Inhibitors of stress
kinase pathways are receiving increasing attention as potential
anti-inflammatory drugs. The precise reconstruction of
stimulus-specific pathways will be instrumental in
predicting/evaluating the effects of the inhibitors on a given
pathological condition. | Introduction |
|---|
|
|
|---|
The analysis of the biochemical cross-talk between Salmonella and epithelial cells has shown that the proteins secreted by the type III secretion system have the capacity to trigger host cell signaling pathways (11). The bacterial product SopE, for instance, activates the small GTPases Cdc42 and Rac-1 (7) and by so doing induces the cytoskeletal changes required for membrane ruffling and for the macropinocytosis of Salmonella (12). A functional type III secretion system is also a prerequisite for the activation of the mitogen-activated protein kinase (MAPK)4 subgroups extracellular-regulated kinase (ERK), Jun N-terminal kinase (JNK), and p38 and for the production of proinflammatory cytokines by epithelial cells infected with Salmonella (13).
For Salmonella as for many other facultative intracellular pathogens the key to a successful infection lies in the outcome of their encounter with the hosts macrophages. Besides playing a crucial role in the immune response against the bacteria, the pro-inflammatory cytokines produced by these cells mediate the early gastrointestinal pathology of the infection (14). Still, much less is known about the molecular mechanisms operating during the interaction of Salmonella typhimurium with macrophages than about the signaling events taking place during epithelial cell invasion. We have previously addressed the question of Salmonella-mediated ERK activation, showing that LPS is the major determinant responsible for ERK stimulation by this pathogen (15). In the present study, we focus on reconstructing the mechanism of JNK activation.
JNK can be stimulated by cellular stress signals like irradiation, heat shock, osmotic stress, and protein synthesis inhibitors (16), and also by growth factors (17, 18). Relevant to our study, this pathway is activated by inflammatory stimuli (19, 20, 21) and upon infection of cultured cells by pathogens, including Gram-negative (13, 22) and Gram-positive bacteria (23). Targeted distruption of the JNK kinase stress and extracellular signal-activated kinase 1 (SEK1) causes defects in the activity of AP-1 (24), a transcription factor implicated in the regulation of cytokine genes (25). Recent data also implicate JNK in the stabilization (26, 27) and translation (28, 29) of cytokine mRNAs. Consistently, T cell differentiation is defective in Jnk-1- (30) and Jnk-2-deficient mice (31).
In this study we show that SEK1 and JNK are activated in a
phagocytosis-independent manner upon infection of macrophages by
Salmonella. Stimulation of JNK, but not of SEK1, involves
the activation of tyrosine kinases, phosphoinositide 3-kinase (PI 3-K),
and, likely, protein kinase C
(PKC
); on the other hand, SEK1
activation depends on the stimulation of phosphatidylcholine
phospholipase C (PC-PLC) and acidic sphingomyelinase (ASMase). Cdc42
and Rac, which mediate JNK activation by a variety of stimuli in many
cell types, are not required for SEK1 or JNK stimulation in
macrophages. Thus, Salmonella activates the JNK pathway in
macrophages by a mechanism that bypasses the canonical activators
Cdc42/Rac and SEK1.
| Materials and Methods |
|---|
|
|
|---|
S. typhimurium strain LT2 (virulent, wild type (wt)) and SB111 (32) were grown in Luria-Bertani (LB) broth (1% bactotryptone, 0.5% yeast extract, and 1% sodium chloride) at 37°C overnight under agitation (poorly invasive). To obtain highly invasive bacteria, bacteria from overnight cultures were diluted to an OD600 of 0.02 in 50 ml fresh LB and incubated for 5 h under agitation 60 .
Cell culture, stimulation, and pretreatment
BAC-1.2F5 cells (33) were cultured in DMEM supplemented with 10% FCS and 20% L cell conditioned medium as a source of CSF-1. Confluent cells (about 5 x 106 cells/100-mm-diameter tissue culture dish) were cultured for 16 h in medium without CSF-1, and then stimulated with 1.5 µg/ml bacterial LPS (from S. typhimurium; Sigma, St. Louis, MO) or infected with bacterial cultures as previously described (15). A multiplicity of infection (moi; bacteria per macrophage) of 25 was used.
Actin polymerization was blocked by pretreatment with 10 µM cytochalasin B (30 min; Sigma). Tyrosine kinases were inhibited by pretreatment with herbimycin A (4 µg/ml for 4 h; Sigma). Activation of PI 3-K was blocked by pretreatment with wortmannin (100 nM, 20 min; Sigma). Rho-family small GTPases (RhoA, Rac1, and Cdc42) were inhibited by a 60-min preincubation with toxin B (34) at a final concentration of 10 or 100 ng/ml. Inhibition of PC-PLC activity was performed by preincubating the cells for 60 min with 10 µM xanthogenate tricyclodecan-9-yl (D609, Alexis Biochemicals, Laufelfingen, Switzerland). PKC was inhibited by treating the cells with 10 µM bisindoleylmaleimide (BIM; Calbiochem, La Jolla, CA) for 60 min before stimulation (35). Diacylglycerol (DAG)-dependent PKC isoforms were down-regulated by a 24-h treatment with 5 µM PMA (Sigma).
Transient transfection
The SuperFect reagent (Qiagen, Basel, Switzerland) was used according to the manufacturers instructions. Macrophages were transfected with an epitope-tagged JNK1 (HA-JNK1, 2 µg/100-mm-diameter culture dish) together either with an epitope-tagged (GST-) SEK wt, or with GST-SEK KR (kinase defective mutant, in which the nucleophilic lysine was substituted for by an arginine), or with pEBG vector as a control (each 8 µg/100-mm-diameter culture dish). Twenty-four hours after transfection, the cells were infected with Salmonella as described above.
Phagocytosis assay
Colony counting assays were performed to assess phagocytosis of S. typhimurium. Briefly, cells (0.05 x 106) were seeded in 96-well plates and infected (moi of 25). Cells were allowed to phagocytose for 30 min and then washed three times with PBS. Fresh medium containing 50 µg/ml gentamicin was added and the cells were incubated for further 60 min to kill residual extracellular bacteria. Thereafter, cells were lysed in PBS supplemented with 0.5% sodium deoxycholate. Serial dilutions of the lysates were prepared in PBS and plated onto the Luria-Bertani agar plates. Colonies were allowed to develop for 18 h before counting. Assays were conducted in triplicates.
Cell lysis, immunoprecipitation and western blotting
Cells were lysed in solubilization buffer (10 mM Tris-base, 50
mM sodium chloride, 30 mM sodium pyrophosphate, 50 mM sodium fluoride,
and 1% Triton X-100, pH 7.0) supplemented with 1 mM PMSF, 100 µM
sodium vanadate, 1 mM DTT, and protease inhibitors (aprotinin (3
µg/ml), pepstatin and leupeptin (each at 0.5 µg/ml)). For
immunoblotting, 3040 µg of whole cell extracts were separated by
10% SDS-PAGE and transferred onto nitrocellulose membranes. For
immunoprecipitation, 500600 µg of whole cell extracts were
incubated in the presence of protein A beads (Amersham, Arlington,
Heights, IL) with anti-PKC
(Santa Cruz Biotechnology, Santa
Cruz, CA) or anti-HA Abs for 1618 h at +4°C. The beads were
collected and washed three times with lysis buffer before elution of
the immunocomplexes by boiling in SDS sample buffer. Membranes were
blocked for 816 h at 4°C in TTBS (10 mM Tris-HCl (pH 8.0), 150 mM
NaCl, and 0.1% Tween 20) supplemented with 4% BSA (fraction V;
Sigma), and probed with the appropriate primary Abs in 1% BSA in TTBS
before incubation with peroxidase-conjugated secondary Abs and
detection by the enhanced chemiluminescence (ECL) system (Pierce,
Rockford, IL). The primary Abs used in this study recognize selectively
phosphorylated JNK1/2 (anti-phJNK,
Thr183/Tyr185), SEK1
(anti-phSEK, Thr223; all from New England
BioLabs, Schwalbach, Germany) and PKC
(36) or their
unmodified forms (Santa Cruz Biotechnology).
PC-PLC and ASMase activity assays
PC-PLC and ASMase activity of whole cell extracts was determined as previously described (37). Briefly, cells (2.5 x 106) were scraped in 2 ml ice-cold PBS and centrifuged for 10 min at 400 rpm at 4°C. A total of 300 µl of Triton X 100 (0.01% for PC-PLC, 0.2% for ASMase activity measurements) were added to the pellet, and the samples were incubated on ice for 10 min before sonication. A total of 15 µg of lysate were incubated for 2 h at 37°C either in PC-PLC buffer (50 mM Tris-HCl (pH 7.3), 6.3 mM CaCl2, 150 mM ammonium sulfate, plus 50 nCi L-3-phosphatidyl[N-methyl-14C]choline ([14C]PC); 80 µl total volume) or in ASMase buffer (250 mM sodium acetate (pH 5.0), 0.2% Triton X 100, plus 50 nCi [methyl-14C]sphingomyelin; 50 µl total volume). Labeled lipids were from Amersham. The PC-PLC assay was terminated by extracting the lipids with CHCl3:CH3OH (1:2 v/v, 180 µl), 0.9% NaCl (60 µl), and CHCl3 (60 µl). The ASMase assay was terminated by extracting the lipids with CHCl3:CH3OH (1:1 v/v, 400 µl) and water (180 µl). The aqueous and organic phases were separated and quantitated by liquid scintillation. The amount of substrate hydrolyzed was quantitated by liquid scintillation counting. PC-PLC and ASMase activity were expressed as percentage of control.
| Results |
|---|
|
|
|---|
Quiescent BAC-1.2F5 cells were infected with Salmonella
for different time periods. The activation state of the
kinases was assessed in whole cell lysates by immunoblotting
with Abs that specifically recognize the phosphorylated, activated form
of each enzyme (Fig. 1
A). All
kinases were activated by Salmonella infection of BAC-1.2F5
cells with fast activation/inactivation kinetics. Peak activation
occurred after 25 min and then decayed. Inactivation was complete by
1 h, and no further changes were observed over a period of 4
h (data not shown). These kinetics of activation resembled those of the
other MAPK subfamily, ERK (15). Highly invasive
Salmonella, which causes apoptosis in macrophages, activates
JNK less efficiently than the poorly invasive form (Fig. 1
A)
and than an invasion-defective mutant (Fig. 1
B).
|
|
Herbimycin A decreases Salmonella-mediated JNK, but not SEK activation
Herbimycin-dependent kinases have previously been implicated in
the activation of PI 3-K (39) and JNK (19, 21) by LPS in monocytes. Salmonella-mediated JNK
activation was also efficiently reduced by herbimycin A (Fig. 3
). However, SEK1 activation was
herbimycin-insensitive, confirming that the pathways targeting SEK1 and
JNK differ in Salmonella-infected macrophages.
|
The results described above suggest that a pathway comprising
herbimycin-sensitive tyrosine kinases and PI 3-K, but independent of
Cdc42/Rac, targets JNK during Salmonella infection. PKC
isoforms can act as PI 3-K downstream effectors both in vitro and in
vivo (36, 40). BAC-1.2F5 cells express the novel
DAG-dependent PKC isoforms
and
, and the atypical PKC
(35), all of which can be inhibited by BIM
(41). Activation of JNK was completely suppressed after
pretreatment with BIM (Fig. 4
A). In agreement with the
hypothesis that distinct pathways cause SEK1 and JNK stimulation by
Salmonella, SEK activation was insensitive to BIM treatment.
Sustained treatment (up to 24 h) with 5 µM PMA, which causes
down-regulation of DAG-dependent PKC isoforms, did not affect JNK
activation (Fig. 4
B). This finding indicates that
DAG-dependent isoforms
and
, which were efficiently degraded
under these conditions (Fig. 4
C), are not involved in
Salmonella stimulation of JNK. Therefore, the effect of BIM
on JNK activation must be due to the inhibition of an atypical
PKC.
|
expression cannot be detected in BAC-1.2F5
macrophages. We monitored the stimulation of the only other known
atypical PKC, PKC
, by S. typhimurium. PKC
can be
activated by PI(3, 4, 5)P3, PI(4, 5)P2, and PI(3, 4)P2 directly
(42) as well as indirectly via phosphorylation by
PI-dependent kinase 1 (36, 40). Activation was monitored
by immunoblotting with Abs that specifically recognize phosphorylation
of the PDK1 site Thr410 in the C-loop of the
PKC
isoform (36). Western blot analysis of whole cell
extracts showed that the phosphorylation reached a maximum 10 min after
infection and then slowly decayed (Fig. 4
(Fig. 4
as a target of
Salmonella downstream of PI 3-K and PDK1. Because the only
other known kinase inhibited by BIM (albeit at higher concentrations)
is protein kinase A (PKA), and this enzyme has never been connected
with JNK activation, the data implicate PKC
in relaying the
Salmonella signal to the JNK module. Involvement of PC-PLC and ASMase in signaling to SEK1
High concentrations of the PC-PLC inhibitor D609 decrease
LPS-mediated stimulation of Raf, MEK, and ERK (35). To
investigate whether phospholipase activation was important for the
stimulation of SEK1 or JNK by Salmonella, we treated
quiescent BAC-1.2F5 cells with low concentrations of D609 (10 µM)
before infection. The inhibitor severely blunted SEK1 activation, but
had only a minor impact on JNK stimulation (Fig. 5
A). The concentration of D609
used is reportedly specific for PC-PLC, and does not affect
phospholipase D (PLD) (43). Furthermore,
Salmonella-induced SEK1 activation was not affected by the
presence of 1% 1-butanol (competitive inhibitor of PLD; Ref.
44 and data not shown). This finding indicated that
PC-PLC, and not PLD, mediated SEK1 activation during infection.
|
Dominant negative SEK1 does not prevent Salmonella-mediated activation of the JNK
The experiments reported above argue that Salmonella-mediated activation of SEK1 and of JNK are regulated independently. To address this question directly, we cotransfected cells with either wt or KR GST-SEK1 and HA-tagged JNK1. Twenty-four hours after transfection cells were either left untreated, treated with LPS, or infected with Salmonella. HA-JNK1 was immunoprecipitated and its activation state was assessed by Western blotting with anti-phJNK Abs.
HA-JNK1 was activated by LPS or Salmonella in cells
cotransfected with wt GST-SEK1. Expression of GST-SEK1 KR significantly
reduced JNK stimulation by LPS but had no effect on
Salmonella-induced JNK activation (Fig. 6
, top panel). Equal amounts
of HA-JNK1 were present in the immunoprecipitates (Fig. 6
, middle
panel). Thus, Salmonella stimulated JNK by a
SEK1-independent mechanism.
|
| Discussion |
|---|
|
|
|---|
In this paper we describe the mechanisms that lead to the activation of
stress-induced kinases after infection of macrophages with
Salmonella. We find that a pathway involving the sequential
activation of PI 3-K/PDK1 and PKC
is responsible for JNK activation.
PC-PLC and ASMase, also activated upon infection, support SEK1 but not
JNK activation. Unexpectedly, stimulation of both SEK1 and JNK is
independent of the function of Cdc42 and Rac.
PI 3-K and atypical PKC are novel intermediates in Rho family-independent JNK activation by Salmonella
Herbimycin A and PI 3-K inhibitors severely blunted
Salmonella-mediated activation of JNK. PI 3-K has been
reported previously to mediate JNK activation by tyrosine kinase and
G-protein coupled receptors (17, 18, 38). However, in all
cases in which this has been investigated, dominant-negative forms of
Cdc42/Rac blocked PI 3-K-dependent JNK activation. In contrast, toxin
B, a bacterial inhibitor of these GTPases, does not prevent the
stimulation of JNK by Salmonella. At the same time, the
ability of the macrophages to phagocytose and, on longer incubations,
their adherence to the substrate (data not shown) were blocked
efficiently, demonstrating that the inhibitor functions to prevent Rho
family-directed cytoskeletal rearrangements in macrophages. Our results
were all the more surprising in view of the fact that both cytoskeletal
reorganization and JNK activation during invasion of epithelial cells
with Salmonella depend on the function of Cdc42 and Rac-1
(7, 12). The most likely explanation for this discrepancy
is that JNK activation is implemented by the bacteria in a
cell-type-specific manner. In favor of this hypothesis, noninvasive
Salmonella mutants are incapable of initiating JNK
activation in epithelial cells (13), whereas they do so in
macrophages. Furthermore, highly invasive Salmonella, which
induces apoptosis in macrophages, activates JNK less efficiently than
poorly invasive bacteria (Fig. 1
B). This phenomenon is
reminiscent of the results obtained with Yersinia spp., in
which invasive, virulent bacteria caused both macrophage apoptosis and
the suppression of MAPK activity (46, 47). It is possible
that Salmonella, like Yersinia (48),
produces an inhibitor of eukaryotic MAPK and translocates it into the
host cell via the type III secretion system.
Conventional, novel, and atypical isoforms of PKC have been previously
implicated in MAPK stimulation (49, 50, 51, 52), and are
downstream targets of PI 3-K (36, 40). During infection of
macrophages with Salmonella, DAG-dependent PKC isoforms are
in fact activated as a result of PI 3-K-mediated stimulation of PLD and
act as intermediates in ERK activation (15).
Salmonella also activates the atypical PKC
(Fig. 4
, D and E) via phosphorylation of
Thr410 in its activation loop by PDK1, a
phosphoinositide-dependent kinase acting downstream of PI-3K (36, 40). Activation of PKC
has mostly been connected with the
stimulation of the ERK pathway (49, 50, 52, 53), although
this enzyme has been shown to modulate the JNK pathway target AP-1
(54, 55). Our data represent the first demonstration that
PKC
is activated downstream of PI 3-K/PDK1 during infection of
macrophages by Salmonella. The participation of this enzyme
in the activation of JNK is supported by the inhibitory effect of BIM
on JNK activation.
PC-PLC and ASMase participate in SEK1 activation by Salmonella
SEK1 activation by Salmonella was resistant to all inhibitors that efficiently prevented JNK stimulation by the bacterium. Besides supporting the specificity of these substances, this indicated that distinct mechanisms target SEK1 and JNK during infection. PC-PLC and ASMase were activated by Salmonella, and treatment with the PC-PLC inhibitor D609 abolished both ASMase and SEK1 activation, leaving JNK stimulation undisturbed. We propose that, as shown in Neisseria gonorrhoeae-infected epithelial cells (56) and in LPS-stimulated macrophages (57), the activation of the PC-PLC/ASMase pathway by Salmonella leads to the generation of ceramide and thereby to SEK1 stimulation. The actual link between ceramide generation and SEK1 activation remains unidentified. The TAK-1 kinase, a SEK1 activator stimulated by endogenous and exogenous ceramides (58), would be a suitable candidate.
SEK1-independent JNK activation by Salmonella in macrophages
The data discussed above demonstrate that distinct mechanisms
implement SEK1 and JNK activation in Salmonella-infected
macrophages. Cross-talk between these two signal transduction pathways
was not observed, and Salmonella-induced JNK activation was
not blocked by a dominant-negative SEK1 mutant. In contrast, the SEK1
dominant-negative mutant inhibited the bulk of JNK activation by LPS in
macrophages (Fig. 6
). These data demonstrate the ability of
extracellular signals to choose the signaling route which leads to MAPK
activation in distinct situations. It is tempting to speculate that
they might do so by modulating the composition of MAPK modules
comprising the dual specificity kinase, its activator, and its
substrate (59). This hypothesis could help explain why
many extracellular signals elicit highly specific responses despite
their apparent use of similar intracellular pathways.
The nature of the JNK activator and of the SEK1 substrate(s) in Salmonella-infected macrophages is at present under investigation.
The data reported here extend our understanding of the biochemical
events induced by the infection of macrophages with
Salmonella, and show for the first time that a pathway
comprising PI 3-K and PKC
leads to JNK activation independently of
Cdc42/Rac and SEK1. Stress kinase pathways involved in cytokine
production are emerging targets for the therapy of a variety of
inflammatory conditions. Understanding the alignment of
stimulus-specific pathways will be important for selecting the
appropriate kinase inhibitor(s) and for the evaluation of their effects
in the context of a given pathological situation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Current address: Protein Phosphorylation Lab, Imperial Cancer Research Fund, London, United Kingdom. ![]()
3 Address correspondence and reprint requests to Dr. Manuela Baccarini, Institute of Microbiology and Genetics, Dr. Bohrgasse 9, A-1030, Vienna, Austria. E-mail address: ![]()
4 Abbreviations used in this paper: MAPK, mitogen-activated protein kinase; ASMase, acidic sphingomyelinase; BIM, bisindoleylmaleimide; DAG, diacylglycerol; ERK, extracellular-regulated kinases; JNK, Jun N-terminal kinases; PC-PLC, phosphatidylcholine phospholipase C; PDK1, phosphoinositide-dependent kinase 1; PI, phosphoinositides; PI 3-K, phosphoinositide 3-kinase; PKC, protein kinase C; SEK1, stress and extracellular signal-activated kinase 1; moi, multiplicity of infection; PLD, phospholipase D; wt, wild type; KR, kinase-defective; HA, hemagglutinin. ![]()
Received for publication June 10, 1999. Accepted for publication August 13, 1999.
| References |
|---|
|
|
|---|
mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb. Pathog. 14:217.[Medline]
(TNF-
) translation: glucocorticoids inhibit TNF-
translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274.[Abstract]
is a mediator of ß
-dependent Jun kinase activation. J. Biol. Chem. 273:2505.
by PI 3-kinase and PDK-1. Curr. Biol. 8:1069.[Medline]
isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:13.
B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.[Medline]
production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 27:953.[Medline]
production. J. Biol. Chem. 272:15920.
. EMBO J. 14:6157.[Medline]
and protein kinase C-
mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor. EMBO J. 18:386.[Medline]
PKC induces phosphorylation and inactivation of I
B-
in vitro. EMBO J. 13:2842.[Medline]
stimulates leukemic cell differentiation. Cell Growth Differ. 5:1195.[Abstract]
This article has been cited by other articles:
![]() |
M. Forsberg, R. Blomgran, M. Lerm, E. Sarndahl, S. M. Sebti, A. Hamilton, O. Stendahl, and L. Zheng Differential effects of invasion by and phagocytosis of Salmonella typhimurium on apoptosis in human macrophages: potential role of Rho-GTPases and Akt J. Leukoc. Biol., October 1, 2003; 74(4): 620 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Savkovic, A. Koutsouris, and G. Hecht PKC{zeta} participates in activation of inflammatory response induced by enteropathogenic E. coli Am J Physiol Cell Physiol, September 1, 2003; 285(3): C512 - C521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lutz and P. H. Correll Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C {zeta} J. Leukoc. Biol., June 1, 2003; 73(6): 802 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Castrillo, P. G. Traves, P. Martin-Sanz, S. Parkinson, P. J. Parker, and L. Bosca Potentiation of Protein Kinase C {zeta} Activity by 15-Deoxy-{Delta}12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-{kappa}B That Promotes Apoptosis in Macrophages Mol. Cell. Biol., February 15, 2003; 23(4): 1196 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Mynott, B. Crossett, and S. R. Prathalingam Proteolytic Inhibition of Salmonella enterica Serovar Typhimurium-Induced Activation of the Mitogen-Activated Protein Kinases ERK and JNK in Cultured Human Intestinal Cells Infect. Immun., January 1, 2002; 70(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |